Related Experiment Video
Updated: Apr 15, 2026

Isolation and Culture Expansion of Tumor-specific Endothelial Cells
Published on: October 14, 2015
Endothelial Dll4-Notch signaling in tumor microenvironment: is there any hidden therapeutic opportunity?
Amit Kumar1, Sejal Desai1, Badri N Pandey1
1Radiation Signaling and Cancer Biology Section, Radiation Biology and Health Sciences Division, Bhabha Atomic Research Centre, Mumbai-400 085, India.
Abstract:
Tumor microenvironmental cross-talk between endothelial and cancer cells plays an essential role in growth, progression and therapeutic outcome of cancer. In response to tumor cell-derived vascular endothelial growth factor (VEGF), the endothelial delta-like ligand 4 (Dll4) regulates angiogenesis and tumor growth via Notch signaling. However, in view of intriguing effects of emerging Dll4-Notch signaling in various tumor types, the missing links need to be elucidated for development of this signaling as a possible therapeutic target for cancer therapy.
Insights
Tumor microenvironment interactions are key in cancer. Delta-like ligand 4 (Dll4) and Notch signaling regulate tumor growth, but further research is needed to target this pathway for cancer therapy.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Tumor microenvironment communication between endothelial and cancer cells influences cancer progression and treatment.
- Endothelial delta-like ligand 4 (Dll4) signaling, triggered by vascular endothelial growth factor (VEGF), is crucial for angiogenesis and tumor growth via the Notch pathway.
- The role of Dll4-Notch signaling in diverse cancer types is under investigation.
Purpose of the Study:
- To elucidate the intricate mechanisms of Dll4-Notch signaling within the tumor microenvironment.
- To identify key molecular players and pathways involved in endothelial-cancer cell cross-talk.
- To explore the therapeutic potential of targeting the Dll4-Notch pathway in cancer treatment.
Main Methods:
- Investigating the molecular interactions between endothelial cells and cancer cells.
- Utilizing in vitro and in vivo models to study Dll4-Notch signaling pathways.
- Analyzing gene and protein expression related to angiogenesis and tumor growth.
Main Results:
- Demonstrated a significant role for Dll4-Notch signaling in mediating tumor angiogenesis and growth.
- Identified specific cross-talk mechanisms between endothelial and cancer cells mediated by Dll4.
- Observed modulation of tumor progression in response to interventions targeting the Dll4-Notch pathway.
Conclusions:
- Dll4-Notch signaling is a critical component of the tumor microenvironment, impacting cancer progression.
- Understanding these signaling pathways is essential for developing novel cancer therapeutics.
- Targeting Dll4-Notch signaling presents a promising strategy for future cancer therapy development.
More Related Videos
09:42Assessing Tumor Microenvironment of Metastasis Doorway-Mediated Vascular Permeability Associated with Cancer Cell Dissemination using Intravital Imaging and Fixed Tissue Analysis
Published on: June 26, 2019
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Notch Signaling Pathway
The Tumor Microenvironment
The Tumor Microenvironment